# Outcome Study of Lanthanum Carbonate Compared With Calcium Carbonate in Hemodialysis Patients : Landmark Study

> **NCT01578200** · PHASE3 · COMPLETED · sponsor: **Translational Research Center for Medical Innovation, Kobe, Hyogo, Japan** · enrollment: 2309 (actual)

## Conditions studied

- Hemodialysis
- Hyperphosphatemia

## Interventions

- **DRUG:** Lanthanum Carbonate
- **DRUG:** Calcium Carbonate

## Key facts

- **NCT ID:** NCT01578200
- **Lead sponsor:** Translational Research Center for Medical Innovation, Kobe, Hyogo, Japan
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2011-12-24
- **Primary completion:** 2019-03-25
- **Final completion:** 2019-03-25
- **Target enrollment:** 2309 (ACTUAL)
- **Last updated:** 2020-11-30

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01578200

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01578200, "Outcome Study of Lanthanum Carbonate Compared With Calcium Carbonate in Hemodialysis Patients : Landmark Study". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT01578200. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*